Concepedia

Impact of aging on immune-related adverse events generated by anti–programmed death (ligand)PD-(L)1 therapies

Capucine Baldini, P. Martin Romano, Anne-Laure Voisin, François‐Xavier Danlos, Stéphane Champiat, Salim Laghouati, Maria Kfoury, H. Vincent, Sophie Postel‐Vinay, Andreea Varga,

European Journal of Cancer · 2020 · 84 citations · 16 references

DOI

Concepts

References

16

Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer

H. Borghaei, L. Paz-Ares, Leora Horn et al. · New England Journal of Medicine · 2015 · 9.5K citations · Full text

, , +17

Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer

Julie R. Brahmer, Karen L. Reckamp, Lucio Crinò et al. · New England Journal of Medicine · 2015 · 8.6K citations · Full text

, , +15

The aging process.

Denham Harman · Proceedings of the National Academy of Sciences · 1981 · 1.9K citations · Full text

, , +17

Natural IgG Autoantibodies Are Abundant and Ubiquitous in Human Sera, and Their Number Is Influenced By Age, Gender, and Disease

Eric P. Nagele, Min Han, Nimish K. Acharya et al. · PLoS ONE · 2013 · 307 citations · Full text

, , +17

Impact of Age on Outcomes with Immunotherapy for Patients with Melanoma

Allison Betof Warner, Ryan David Nipp, Anita Giobbie‐Hurder et al. · The Oncologist · 2017 · 202 citations · Full text

, , +17